[HTML][HTML] Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
H Nakase, M Uchino, S Shinzaki, M Matsuura… - Journal of …, 2021 - Springer
Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
EJ Villablanca, K Selin, CRH Hedin - Nature Reviews Gastroenterology …, 2022 - nature.com
Almost all currently available treatments for inflammatory bowel disease (IBD) act by
inhibiting inflammation, often blocking specific inflammatory molecules. However, given the …
inhibiting inflammation, often blocking specific inflammatory molecules. However, given the …
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment
Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …
inflammation extending to a variable extent from the rectum. Care of the patient with UC …
ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease
T Kucharzik, P Ellul, T Greuter, JF Rahier… - Journal of Crohn's …, 2021 - academic.oup.com
The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …
Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international …
Background and Aims The impact of Coronavirus disease 2019 (COVID-19) on patients with
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Objective We sought to evaluate COVID-19 clinical course in patients with IBD treated with
different medication classes and combinations. Design Surveillance Epidemiology of …
different medication classes and combinations. Design Surveillance Epidemiology of …
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Background Anti-TNF drugs are effective treatments for the management of Crohn's disease
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …
but treatment failure is common. We aimed to identify clinical and pharmacokinetic factors …
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot …
H Yanai, A Levine, A Hirsch, RS Boneh… - The Lancet …, 2022 - thelancet.com
Summary Background The Crohn's disease exclusion diet (CDED) with partial enteral
nutrition is effective for induction of remission in children with mild-to-moderate Crohn's …
nutrition is effective for induction of remission in children with mild-to-moderate Crohn's …
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
2. Methods Based on the GRADE workflow, the Guidelines Committee of ECCO [GuiCom]
selected a panel of 48 experts supported by a team of methodologists and librarians …
selected a panel of 48 experts supported by a team of methodologists and librarians …
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
C Bezzio, S Saibeni, A Variola, M Allocca, A Massari… - Gut, 2020 - gut.bmj.com
Objectives COVID-19 has rapidly become a major health emergency worldwide. Patients
with IBD are at increased risk of infection, especially when they have active disease and are …
with IBD are at increased risk of infection, especially when they have active disease and are …